Abstract
Ceftazidime-avibactam and comparator antibiotics were tested by the broth microdilution method against 200 Enterobacteriaceae and 25 Pseudomonas aeruginosa strains resistant to fluoroquinolones (including strains with the extended-spectrum β-lactamase [ESBL] phenotype and ceftazidime-resistant strains) collected from our institution. The MICs and mechanisms of resistance to fluoroquinolone were also studied. Ninety-nine percent of fluoroquinolone-resistant Enterobacteriaceae strains were inhibited at a ceftazidime-avibactam MIC of ≤4 mg/liter (using the susceptible CLSI breakpoint for ceftazidime alone as a reference). Ceftazidime-avibactam was very active against ESBL Escherichia coli (MIC90 of 0.25 mg/liter), ESBL Klebsiella pneumoniae (MIC90 of 0.5 mg/liter), ceftazidime-resistant AmpC-producing species (MIC90 of 1 mg/liter), non-ESBL E. coli (MIC90 of ≤0.125 mg/liter), non-ESBL K. pneumoniae (MIC90 of 0.25 mg/liter), and ceftazidime-nonresistant AmpC-producing species (MIC90 of ≤0.5 mg/liter). Ninety-six percent of fluoroquinolone-resistant P. aeruginosa strains were inhibited at a ceftazidime-avibactam MIC of ≤8 mg/liter (using the susceptible CLSI breakpoint for ceftazidime alone as a reference), with a MIC90 of 8 mg/lite...Continue Reading
References
May 1, 1995·Antimicrobial Agents and Chemotherapy·J VilaT Jimenez de Anta
Oct 1, 1994·Antimicrobial Agents and Chemotherapy·J VilaT Jimenez de Anta
Feb 1, 1996·Antimicrobial Agents and Chemotherapy·J VilaM T De Anta
Dec 11, 1999·The Journal of Antimicrobial Chemotherapy·M M NaviaJ Vila
Feb 27, 2001·The Journal of Antimicrobial Chemotherapy·D M Livermore
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patricia A BradfordJohn Quale
Jun 17, 2009·Antimicrobial Agents and Chemotherapy·Andrea EndimianiRobert A Bonomo
Dec 1, 2009·PloS One·Anna FàbregaJordi Vila
Aug 31, 2010·The Journal of Antimicrobial Chemotherapy·Shazad MushtaqDavid M Livermore
Nov 3, 2010·Antimicrobial Agents and Chemotherapy·David M LivermoreNeil Woodford
Mar 2, 2011·Antimicrobial Agents and Chemotherapy·P R S Lagacé-WiensG G Zhanel
Jun 3, 2011·Journal of Clinical Microbiology·Athanassios TsakrisDanai Sofianou
Nov 2, 2011·International Journal of Antimicrobial Agents·Z AktaşO Oncul
Feb 2, 2013·Drugs·George G ZhanelJames A Karlowsky
Aug 24, 2013·The Lancet Infectious Diseases·L Silvia Munoz-PriceJohn P Quinn
Jan 1, 2014·Antimicrobial Agents and Chemotherapy·Helio S SaderRonald N Jones
Feb 25, 2014·The Journal of Antimicrobial Chemotherapy·Robert K FlammRonald N Jones
Aug 17, 2014·Diagnostic Microbiology and Infectious Disease·Robert K FlammRonald N Jones
Citations
Oct 18, 2016·MedChemComm·Jed F Fisher, Shahriar Mobashery
Mar 8, 2016·Clinical Therapeutics·Roopali SharmaStanley Moy
Apr 5, 2016·Expert Review of Anti-infective Therapy·Bradley J Gardiner, Yoav Golan
Jun 15, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Adnan AlatoomImran Mirza
Nov 8, 2017·Infection·Felipe Francisco TuonMarcelo R Formigoni-Pinto
Aug 3, 2016·Antimicrobial Agents and Chemotherapy·Gabriel TorrensAntonio Oliver
Aug 8, 2018·Antimicrobial Agents and Chemotherapy·Fernando Sanz-GarcíaJosé Luis Martínez
Aug 2, 2018·BioMed Research International·Fu LiKanglin Wan
Aug 4, 2019·Southern Medical Journal·C Whitney WhiteJacob Campbell
Dec 3, 2020·Tropical Medicine and Infectious Disease·Purity Z KuboneSabiha Y Essack